Article
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 15 Jan 2004
Casula Milena, Colombino Maria, Satta Maria P, Cossu Antonio, Ascierto Paolo A, Bianchi-Scarrà Giovanna, Castiglia Daniele, Budroni Mario, Rozzo Carla, Manca Antonella, Lissia Amelia, Carboni Annangela, Petretto Elisabetta, Satriano Sabrina M R, Botti Gerardo, Mantelli Michela, Ghiorzo Paola, Stratton Michael R, Tanda Francesco, Palmieri Giuseppe
Abstract excerpt
PURPOSE: Ocogenic activation of the BRAF gene has been demonstrated to be involved in the pathogenesis of malignant melanoma (MM). In this study, we investigated the contribution of BRAF to melanoma susceptibility, also making a comparison with frequency of CDKN2A germline mutations in MM patients from different areas in Italy. PATIENTS AND METHODS: sing a combination of denaturing high-performance liquid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
